MAPS, DATA, AND RESOURCES

Asthma in Children
Figure 1:	All ISAAC centres by phase	map
Figure 2:	Asthma symptoms among 13-14 year olds	map
Figure 3:	Severe asthma among 13-14 year olds with current wheeze	map
Figure 4:	Changes in asthma prevalence among 13-14 year olds ranked by affluence and mean change per year	graph
Figure 5:	Change in prevalence of current wheeze: 13-14 year olds	map

Asthma in Adults
Table:	Range of prevalence for common outcomes related to asthma from the first European Community Respiratory Health Survey	table
Figure 1:	Prevalence of wheeze and asthma according to Gross National Income (GNI)	map
Figure 2:	Proportions of participants with any asthma whose asthma was graded Severe, Moderate or Mild in the AIRE studies	map
Figure 3:	Proportions of participants with persistent asthma whose asthma was graded Severe, Moderate or Mild in the AIRE studies	map

Essential Medicines: Pricing, Availability and Affordability
Figure 1:	Countries included in the essential asthma medicines survey 2011	map
Table 1:	Median price of surveyed inhalers in 50 low- and middle-income countries	table
Table 2:	Availability of surveyed inhalers by country, type of health facility and national Essential Medicines List (EML)	table
Figure 2:	Affordability of Beclometasone 100μg inhaler in private pharmacies	graph

The Role of Guidelines in Managing Asthma
Figure 1:	Asthma guidelines for children in ISAAC countries, Asthma guidelines for adults in ISAAC countries	graph
Figure 2:	Asthma management guidelines for children in ISAAC countries	map
Figure 3:	Asthma management guidelines for adults in ISAAC countries	map

Appendix: Tables and Figures
Table 1:	ISAAC world map data, symptoms of asthma	table
Table 2:	National asthma guidelines in countries participating in ISAAC	table
Figure 1:	Asthma guidelines for children in ISAAC countries	graph
Figure 2:	Asthma guidelines for adults in ISAAC countries	graph
Figure 3:	Affordability of Salbutamol 100μg inhaler in private pharmacies	graph
Figure 4:	Affordability of Budesonide 200μg inhaler in private pharmacies	graph